BMS-754807
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for BMS-754807, covering 2011-11-30 to 2019-07-11. Get the full timeline:
Most recent: Clinical Trial Update: Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase Inhibitors [Phase 2]